, Tracking Stock Market Picks
Enter Symbol:
Allergan, Inc. (AGN) [hlAlert]

up 369.72 %

Allergan, Inc. (AGN) rated Outperform with price target $119 by RBC Capital Mkts

Posted on: Thursday,  May 2, 2013  10:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Allergan, Inc. (NYSE: AGN) on 05/02/2013. Previously RBC Capital Mkts rated Outperform Allergan, Inc. (NYSE: AGN) on
09/17/2010., when the stock price was $65.14. Since then, Allergan, Inc. has gained 369.73% as of 11/24/2015's recent price of $305.98.
If you would have followed the previous RBC Capital Mkts's recommendation on AGN, you would have gained 369.72% of your investment in 1894 days.

Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. The Company is engaged in discovering, developing and commercializing specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries globally. In January 2007, the Company completed the acquisition of Groupe Corneal Laboratoires (Corneal). In October 2007, the Company completed the acquisition of Esprit Pharma Holding Company, Inc. (Esprit). In July 2008, the Company acquired the Aczone (dapsone) gel 5% from QLT USA, Inc. (QLT), a wholly owned subsidiary of QLT Inc. The Company operates in two business segments: specialty pharmaceuticals and medical devices.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/2/2013 10:25 AM Buy
102.35 119.00
as of 12/13/2013
1 Week down  -1.65 %
1 Month up  1.86 %
3 Months up  8.78 %
1 YTD up  5.27 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/30/2012 2:25 PM Buy
95.49 106.00
2/3/2011 8:25 AM Buy
71.42 82.00
10/18/2010 9:25 AM Buy
71.85 80.00
9/17/2010 9:25 AM Buy
65.14 77.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy